acne vulgaris. Disease of skin appendages
Conditions
Interventions
Intervention 1: Control group: Doxycycline, 100mg, daily, for 12 weeks. Intervention 2: Intervention group: Zinc sulphate, 30mg, daily for 12 weeks.
Treatment - Drugs
Control group: Doxycycline, 100mg, daily, for 12 weeks
Intervention group: Zinc sulphate, 30mg, daily for 12 weeks
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 18-40 years old – mild to moderate acne – acne since more than 2 months ago Exclusion criteria: severe and nodulocystic acne – pregnancy and breast feeding – other skin disease in face – use of systemic and topical steroids, lithium, B group vitamins, iodide or bromium, antibacterial soap and antiseptic soloutions, oral and topical antibiotics and zinc and systemic and topical anti acne drugs in recent 1 month and isotretinoin in recent 2 months and antiacid drugs and calcium and iron based agents
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne improvment. Timepoint: Before intervention, 4 Weeks later, 8 weeks later, 12 weeks later. Method of measurement: Counting of lesions (scoring). | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease of inflammatory and non inflammatory lesions. Timepoint: Before intervention, 4 weeks later, 8 weeks later, 12 weeks later. Method of measurement: Counting of lesions(scoring). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Effat Khodaeiani
Tabriz University of Medical Sciences
Outcome results
None listed